The market launch is planned to happen as soon as possible following AlzChem Group AG's termination of its supply agreement with Evonik, which will go into effect on December 31 this year.
The GAA product, CreAMINO, currently distributed by Evonik, is manufactured by AlzChem.
Evonik will continue to supply its customers until at least the end of 2018. The termination of the contract with AlzChem AG will open options for Evonik to further develop the use of GAA in animal nutrition and to supply the global market with its own GAA product.
"With our comprehensive animal nutrition expertise and our broad portfolio of feed additives, we are the perfect partner for the use of GAA in modern feeding concepts," said Dr. Emmanuel Auer, head of animal nutrition business line at Evonik. "The product is an important element in healthy, efficient and sustainable animal nutrition. That is why we are working hard on a new solution and are pleased to take full ownership of GAA production."
Guanidinoacetic acid is an essential component for the organism in building creatine. It also serves as a key source of arginine. Creatine is vital for vertebrates as it contributes to ensuring that the muscle cells are supplied with energy. With the addition of GAA to animal feed, feed conversion can be improved.